VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $363,000 | -30.7% | 3,570 | +21.6% | 0.09% | -36.0% |
| Q3 2015 | $524,000 | -26.0% | 2,936 | -7.8% | 0.14% | -25.3% |
| Q2 2015 | $708,000 | +2.8% | 3,186 | -8.1% | 0.18% | +2.8% |
| Q1 2015 | $689,000 | +34.3% | 3,467 | -3.2% | 0.18% | +32.1% |
| Q4 2014 | $513,000 | +6.2% | 3,583 | -2.7% | 0.13% | -6.9% |
| Q3 2014 | $483,000 | +4.1% | 3,681 | 0.0% | 0.14% | +3.6% |
| Q2 2014 | $464,000 | +38.1% | 3,681 | +44.4% | 0.14% | +26.4% |
| Q1 2014 | $336,000 | – | 2,550 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |